Yael Margolin has more than 35 years of experience in the biotech, pharmaceutical and venture capital industries. Served as CEO, President and Board Member of Gamida Cell (GMDA), leading the company from preclinical development through successful phase 3 international registration studies. Former Vice President of Denali Ventures LLC, a venture capital firm focused on healthcare, and a programs manager at Teva Pharmaceuticals. Currently a board member and Advisor to several public and private companies in the Healthtech industry. Established Mentoring@8400, a boutique voluntary mentoring program for young CEOs in Israel. Holds a Ph.D. in Biology from the Weizmann Institute of Science and was a post-doctoral associate at Yale University